ChREBP deficiency aggravates diabetic sarcopenia by disrupting glucose signaling: a novel mouse model of muscle atrophy

Journal of Endocrinology · Published 2026-01-01 · DOI 10.1530/joe-25-0257

Authors being retrieved — see the publisher record. https://doi.org/10.1530/joe-25-0257

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Clocks on steroids: how glucocorticoid receptors tell cells the time · Journal of Endocrinology · 2026 · Same journal
• Advanced neuroimaging in PCOS: state-of-the-art techniques and emerging trends · Journal of Endocrinology · 2026 · Same journal
• A TIMELESS link to dedifferentiation in thyroid cancer · Journal of Endocrinology · 2025 · Same journal
• Comparison of serum adipocyte fatty acid binding protein (A-FABP) levels in prediabetic patients and healthy individuals · Journal of Endocrinology · 2026 · Same journal
• Renal Vdr deletion drives urinary calcium loss with intestinal and skeletal compensatory responses · Journal of Endocrinology · 2026 · Same journal
• Tmem119 is involved in the bone repair enhanced by parathyroid hormone in female mice · Journal of Endocrinology · 2026 · Same journal
• PTEN regulation by miR-486-5p contributes to the amelioration of polycystic ovary syndrome · Journal of Endocrinology · 2025 · Same journal
• Experimental chronic fetal hyperglucagonemia stimulates hepatic pathways for amino acid catabolism and gluconeogenesis · Journal of Endocrinology · 2026 · Same journal
• Downregulation of SLC32A1 mediates the PAI-1 pathway in alleviating hepatic stellate cell activation and liver fibrosis · Journal of Endocrinology · 2026 · Same journal
• Tissue-specific expression and regulation of the mineralocorticoid receptor during development · Journal of Endocrinology · 2026 · Same journal